Alter M, Sobel E, McCoy RL, Francis ME, Davanipour A, Sofer F, Levitt LP, Meehan EF (1987) Stroke in the Lehigh Valley: risk factors for recurrent stroke. Neurology 37:503–507
Google Scholar
Broekmans AW, Veltkamp JJ, Bertina RM (1983) Congenital protein C deficiency and venous thromboembolism: a study of three Dutch families. N Engl J Med 309:340–344
Google Scholar
Chong BH, Pitney WR, Castaldi PA (1982) Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet II:1246–1249
Google Scholar
D'Angelo A, Landi L, Vigano'D'Angelo S, Orazio EN, Boccardi E, Candelise L, Mannucci PM (1988) Protein C in acute stroke. Stroke 19:579–583
Google Scholar
Donnan GA (1986) In hospital stroke and TIA recurrence rates. In: Donnan GA, Vajda F (eds) Perspective in stroke. York Press, Victoria, pp 119–125
Google Scholar
Epstein DJ, Bergum PW, Rapaport SI (1983) Kinetics of protein C depression after Coumadin administration. Circulation 68 (Suppl III):1264
Google Scholar
Kubota K, Sakurai T, Tamura J, Sirakura T (1987) Is the circadian change in hematocrit and blood viscosity a factor triggering cerebral and myocardial infarction? Stroke 18:812–813
Google Scholar
Marciniak E, Gockerman JP (1977) Heparin induced decrease in circulating antithrombin III. Lancet II:581–584
Google Scholar
Marshall J (1977) Diurnal variation in occurrence of strokes. Stroke 8:230–231
Google Scholar
Millar-Craig MW, Bishop CN, Raftery EB (1987) Circadian variation of blood pressure. Lancet I:795–797
Google Scholar
Muller JE, Stone PH, Turi AZ, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T, Sobel BE, Willerson JT, Braunwald E (1985) Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 313:1315–1322
Google Scholar
Ramierz-Lassepas M, Cipolle RJ, Rodvold KA, Seifert RD, Strand L, Taddeini L, Cusulos M (1984) Heparin-induced thrombocytopenia in patients with cerebrovascular disease. Neurology 34:736–740
Google Scholar
Ramirez-Lassepas M, Quinones MR, Nino HH (1986) Treatment of acute ischemic stroke — open trial with continuous intravenous heparinization. Arch Neurol 43:386–390
Google Scholar
Rao AK, Niewiarowski S, Guzzo J, Day HJ (1981) Antithrombin III levels during heparin therapy. Thromb Res 24:181–186
Google Scholar
Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR (1988) Determinants in early recurrence of cerebral infarction: Stroke Data Bank. Stroke 19:144
Google Scholar
Slivka AP, Levy DE (1987) Risk associated with heparin withdrawal in ischemic cerebrovascular disease. Stroke 18:298
Google Scholar
Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE (1987) Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 316:1514–1518
Google Scholar
Turton MB, Deegan T (1974) Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects. Clin Chim Acta 55:389–397
Google Scholar